Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Clene Inc.CLNN · Entity 7166 | Director | August 13, 2026 | August 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Clene Inc.
Report date August 13, 2026 · Filed August 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| stock optionSEC Table II · derivative / convertible security · Conversion / exercise price $4.19 · Expires 2036-08-12 | Direct | 3,195 |
Reported balance
After 2026-08-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-13 · Grant · Acquired 3,195 · Balance 3,195 F1: This option was granted on August 13, 2026 as an option for 3,195 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant. |
Filing footnotes · ownership attribution and instrument terms
F1: This option was granted on August 13, 2026 as an option for 3,195 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 13, 2026 Filed Aug 14, 2026 19:32 UTC | Clene Inc. CLNN · Entity 7166 | Grantstock option · Derivative | 3,195 | $0.00 Strike: $4.19 | $0.00 |
DisclosureSEC source: 0001437749-26-027973 · rdgdoc.xml · derivative · entry 1 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,195 Underlying: common stock · 3,195 shares Expires 2036-08-12 F1 · derivative.exercise_date: This option was granted on August 13, 2026 as an option for 3,195 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant. Read SEC document |
| May 21, 2026 Filed May 22, 2026 17:55 UTC | Clene Inc. CLNN · Entity 7166 | Grantstock option · Derivative | 1,876 | $0.00 Strike: $6.81 | $0.00 |
DisclosureSEC source: 0001437749-26-018216 · rdgdoc.xml · derivative · entry 2 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,876 Underlying: common stock · 1,876 shares Expires 2036-05-20 F2 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 1,876 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant. Read SEC document |
| May 21, 2026 Filed May 22, 2026 17:55 UTC | Clene Inc. CLNN · Entity 7166 | Grantstock option · Derivative | 1,500 | $0.00 Strike: $6.81 | $0.00 |
DisclosureSEC source: 0001437749-26-018216 · rdgdoc.xml · derivative · entry 1 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: common stock · 1,500 shares Expires 2036-05-20 F1 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 21:01 UTC | Clene Inc. CLNN · Entity 7166 | Grantstock option · Derivative | 2,755 | $0.00 Strike: $4.73 | $0.00 |
DisclosureSEC source: 0001437749-26-004897 · rdgdoc.xml · derivative · entry 1 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,755 Underlying: common stock · 2,755 shares Expires 2036-02-18 F1 · derivative.exercise_date: This option was granted on February 19, 2026 as an option for 2,755 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 21:48 UTC | Clene Inc. CLNN · Entity 7166 | Grantstock option · Derivative | 1,893 | $0.00 Strike: $7.30 | $0.00 |
DisclosureSEC source: 0001437749-25-035232 · rdgdoc.xml · derivative · entry 1 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,893 Underlying: common stock · 1,893 shares Expires 2035-11-12 F1 · derivative.exercise_date: This option was granted on November 13, 2025 as an option for 1,893 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $7.30 per share. The options vest immediately upon grant. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 13:11 UTC | Clene Inc. CLNN · Entity 7166 | Grantstock option · Derivative | 3,720 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001437749-25-027073 · rdgdoc.xml · derivative · entry 1 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,720 Underlying: common stock · 3,720 shares Expires 2035-08-13 F1 · derivative.exercise_date: This option was granted on August 14, 2025 as an option for 3,720 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $3.60 per share. The options vest immediately upon grant. Read SEC document |
| May 22, 2025 Filed May 23, 2025 19:09 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 5,236 | $0.00 Strike: $2.45 | $0.00 |
DisclosureSEC source: 0001562180-25-004128 · primarydocument.xml · derivative · entry 2 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,236 Underlying: Common Stock · 5,236 shares Expires 2035-05-21 F2 · derivative.exercise_date: This option was granted on May 22, 2025 as an option for 5,236 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $2.45 per share. The options vest immediately upon grant. Read SEC document |
| May 22, 2025 Filed May 23, 2025 19:09 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 1,500 | $0.00 Strike: $2.45 | $0.00 |
DisclosureSEC source: 0001562180-25-004128 · primarydocument.xml · derivative · entry 1 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2035-05-21 F1 · derivative.exercise_date: This option was granted on May 22, 2025 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $2.45 per share. The options vest in 12 equal monthly installments on the 22nd day of each calendar month, beginning June 22, 2025, until such shares are fully vested. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:22 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 2,886 | $0.00 Strike: $4.42 | $0.00 |
DisclosureSEC source: 0001562180-25-001811 · primarydocument.xml · derivative · entry 1 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,886 Underlying: Common Stock · 2,886 shares Expires 2035-02-26 F1 · derivative.exercise_date: This option was granted on February 27, 2025 as an option for 2,886 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.42 per share. The options vest immediately upon grant. Read SEC document |
| December 06, 2024 Filed Dec 9, 2024 21:15 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 2,853 | $0.00 Strike: $4.40 | $0.00 |
DisclosureSEC source: 0001562180-24-008235 · primarydocument.xml · derivative · entry 1 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,853 Underlying: Common Stock · 2,853 shares Expires 2034-12-05 F1 · derivative.exercise_date: This option was granted on December 6, 2024 as an option for 2,853 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.40 per share. The options vest immediately upon grant. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 20:07 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 2,559 | $0.00 Strike: $4.89 | $0.00 |
DisclosureSEC source: 0001562180-24-007206 · primarydocument.xml · derivative · entry 1 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,559 Underlying: Common Stock · 2,559 shares Expires 2034-10-01 F1 · derivative.exercise_date: This option was granted on October 2, 2024 as an option for 2,559 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.89 per share. The options vest immediately upon grant. Read SEC document |
| June 07, 2024 Filed Jun 10, 2024 20:15 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 33,704 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001562180-24-004890 · primarydocument.xml · derivative · entry 1 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,704 Underlying: Common Stock · 33,704 shares Expires 2034-06-06 F1 · derivative.exercise_date: This option was granted on June 7, 2024 as an option for 33,704 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest immediately upon grant. Read SEC document |
| May 29, 2024 Filed May 31, 2024 16:06 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 30,000 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001562180-24-004530 · primarydocument.xml · derivative · entry 1 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-05-28 F1 · derivative.exercise_date: This option was granted on May 29, 2024 as an option for 30,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest in 12 equal installments of Common Stock on the 29th day of each calendar month, beginning June 29, 2024, until such shares are fully vested. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 20:20 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 29,481 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001562180-24-002595 · primarydocument.xml · derivative · entry 1 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,481 Underlying: Common Stock · 29,481 shares Expires 2034-03-11 F1 · derivative.exercise_date: This option was granted on March 11, 2024 as an option for 29,481 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.44 per share. The options vest immediately upon grant. Read SEC document |
| November 28, 2023 Filed Nov 29, 2023 21:09 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 28,730 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001562180-23-007967 · primarydocument.xml · derivative · entry 1 Kiernan Matthew · CIK 0001993183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,730 Underlying: Common Stock · 28,730 shares Expires 2033-11-28 F1 · derivative.exercise_date: This option was granted on November 28, 2023 as an option for 28,730 shares of Common Stock under the Clene Inc. 2020 Amended Stock Plan at an exercise price of $0.45 per share. The options vest immediately upon grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.